Digitisation | March 08, 2024
India approves Rs. 10,300 crore for AI Mission
The investment will catalyse various components of the IndiaAI Mission
The investment will catalyse various components of the IndiaAI Mission
ANVISA issues CGMP to Concord Biotech’s Unit I
This agreement paves the way for the introduction of YESAFILI into the Canadian market
Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg
Cipla completes transfer of Generics Business Undertaking
_256_384.jpg)
The overall transaction is expected to conclude over next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals
The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy
The board gave in-principle approval for expansion of company's footprint in Lucknow
The observations do not pose any risk to site's compliance standards or its business continuity
Leishmaniasis is caused by protozoan parasites which are transmitted by the bite of infected female phlebotomine sandflies
Subscribe To Our Newsletter & Stay Updated
